Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AOC3 | Q16853 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 5/20 | 0.44 |
| ▸ | MEN1 | O00255 | 2/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.44 |
| ▸ | G6PD | P11413 | 1/20 | 0.44 |
| ▸ | CYP11B2 | P19099 | 2/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.42 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.41 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | NPBWR1 | P48145 | 1/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.40 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.40 |
| ▸ | ATM | Q13315 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10110966 | 0.93 | ALDH1A1 (0.49) | AOC3MAPTMEN1KMT2AG6PD | |
| SCHEMBL10111100 | 0.93 | ALDH1A1 (0.48) | AOC3MAPTMEN1KMT2AG6PD | |
| SCHEMBL10111078 | 0.92 | ALDH1A1 (0.45) | AOC3MAPTMEN1KMT2AG6PD | |
| SCHEMBL13805183 | 0.91 | G6PD (0.41) | AOC3MAPTMEN1KMT2AHSP90AA1 | |
| SCHEMBL2745014 | 0.90 | KMT2A (0.52) | MAPTMEN1KMT2AHSP90AA1HSD17B10 | |
| SCHEMBL10111075 | 0.90 | KDM4E (0.48) | AOC3MAPTMEN1KMT2AHSP90AA1 | |
| SCHEMBL10111070 | 0.89 | HSD17B10 (0.51) | MAPTMEN1KMT2AHSP90AA1HSD17B10 | |
| SCHEMBL10110997 | 0.88 | KDM4E (0.49) | MEN1KMT2ACYP11B2HSD17B10KDM4E | |
| SCHEMBL15468815 | 0.88 | G6PD (0.43) | AOC3MAPTMEN1KMT2AHSP90AA1 | |
| SCHEMBL10111101 | 0.86 | KDM4E (0.55) | MAPTMEN1KMT2AHSP90AA1HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10790451-B2 | Triazole derivative, and light-emitting element, light-emitting device, and electronic device with the use of triazole derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2020-09-29 | — | — | US | disclosed |
| US-20160268515-A1 | TRIAZOLE DERIVATIVE, AND LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, AND ELECTRONIC DEVICE WITH THE USE OF TRIAZOLE DERIVATIVE | SEMICONDUCTOR ENERGY LAB (JP) | 2016-09-15 | — | — | US | disclosed |
| US-20160268515-A1 | TRIAZOLE DERIVATIVE, AND LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, AND ELECTRONIC DEVICE WITH THE USE OF TRIAZOLE DERIVATIVE | SEMICONDUCTOR ENERGY LAB (JP) | 2016-09-15 | — | — | US | disclosed |
| US-20120199818-A1 | TRIAZOLE DERIVATIVE, AND LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, AND ELECTRONIC DEVICE WITH THE USE OF TRIAZOLE DERIVATIVE | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2012-08-09 | — | — | US | disclosed |
| US-20120199818-A1 | TRIAZOLE DERIVATIVE, AND LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, AND ELECTRONIC DEVICE WITH THE USE OF TRIAZOLE DERIVATIVE | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2012-08-09 | — | — | US | disclosed |
| US-8178217-B2 | 4-(4-bromophenyl)-3,5-diphenyl-4H-1,2,4-triazole; high triplet excitation energy; high luminous efficiency, low power consumption | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2012-05-15 | — | — | US | disclosed |
| US-8178217-B2 | 4-(4-bromophenyl)-3,5-diphenyl-4H-1,2,4-triazole; high triplet excitation energy; high luminous efficiency, low power consumption | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2012-05-15 | — | — | US | disclosed |
| WO-2008143019-A1 | TRIAZOLE DERIVATIVE, AND LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, AND ELECTRONIC DEVICE WITH THE USE OF TRIAZOLE DERIVATIVE | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2008-11-27 | — | — | WO | disclosed |
| US-20080286607-A1 | Triazole derivative, and light-emitting device, and electronic device with the use of triazole derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2008-11-20 | — | — | US | disclosed |
| US-20080286607-A1 | Triazole derivative, and light-emitting device, and electronic device with the use of triazole derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2008-11-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120199818-A1 | TRIAZOLE DERIVATIVE, AND LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, AND ELECTRONIC DEVICE WITH THE USE OF TRIAZOLE DERIVATIVE | TYR, TH, YEATS4 | AOC3 147/4885MAPT 2450/4885MEN1 3934/4885 |
| US-20160268515-A1 | TRIAZOLE DERIVATIVE, AND LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, AND ELECTRONIC DEVICE WITH THE USE OF TRIAZOLE DERIVATIVE | TYR, TH, YEATS4 | AOC3 147/4885MAPT 2450/4885MEN1 3934/4885 |
| US-10790451-B2 | Triazole derivative, and light-emitting element, light-emitting device, and electronic device with the use of triazole derivative | TYR, TH, YEATS4 | AOC3 147/4885MAPT 2450/4885MEN1 3934/4885 |
| US-20080286607-A1 | Triazole derivative, and light-emitting device, and electronic device with the use of triazole derivative | TYR, TH, CYP3A4 | AOC3 153/4885MAPT 2676/4885MEN1 3872/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.